FAS/FASL or other death receptor targeted methods and compositions for killing tumor cells

Details for Australian Patent Application No. 2009303355 (hide)

Owner Promising Future, LCC

Inventors Kruse, Carol; Tritz, Richard

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2009303355

PCT Pub. Number WO2010/045369

Priority 61/105,550 15.10.08 US; 61/229,231 28.07.09 US

Filing date 14 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/045369 Priority application(s): WO2010/045369

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303368-Pegylation of recombinant blood coagulation factors in the presence of bound antibodies

2009303354-Food compositions of microalgal biomass